Biologics access threatened by US-Mexico-Canada agreement, says biosimilar industry 03-Oct-2018 By Flora Southey The US, Mexico and Canada have agreed a trade deal that includes 10 years of data protection for biologics.
How the US-Mexico trade deal could impact the biologics market 17-Sep-2018 By Ben Hargreaves BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lione’s biopharma practice group, the provisional detail revealed from the US administration’s proposed trade deal with Mexico, and its potential impact on the...